tirzepatide for menopause weight gain GLP-1s, Obesity, and Menopause: Benefits and Risks Mounjaro for Menopause Weight Gain:

Always confirm benefits and potential reimbursement options directly with your insurer

Tirzepatide , originally developed for type 2 diabetes, works as a dual agonist targeting the GIP and GLP-1 receptors, both of which are integral to appetite control, insulin regulation, and energy balancekey factors in effective weight management

In addition, some individuals find it easier to maintain healthier eating habits because cravings become more manageable

Instead, it is a molecule your own cells produce

*In 68- and 72-week clinical trials, Tirzepatide was evaluated in patients without diabetes who had a BMI of 30 or a BMI of 27 with a weight-related condition